Combined use of iron syrup and ranitidine for magnetic resonance cholangiopancreatography scan.
Not Applicable
- Conditions
- Health Condition 1: K85- Acute pancreatitisHealth Condition 2: K81- CholecystitisHealth Condition 3: K80- CholelithiasisHealth Condition 4: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhereHealth Condition 5: K83- Other diseases of biliary tractHealth Condition 6: K82- Other diseases of gallbladderHealth Condition 7: K86- Other diseases of pancreas
- Registration Number
- CTRI/2019/04/018466
- Lead Sponsor
- Aravintho
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients above 18 years of age referred for magnetic resonance cholangiopancreatography.
Exclusion Criteria
1.Patients with MRI incompatible implant or aneurysm/surgical clips or metallic sutures,
2.Patients with history suggestive of foreign body
3.Patients with prior hepatobiliary surgery/stenting
4.Scans of patient with poor quality due to other technical factors like movement artifact.
5.Patients allergic to haematinic syrup and/or ranitidine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Qualitative assessment of image quality using semiquantitative scoring systemTimepoint: After 12 months
- Secondary Outcome Measures
Name Time Method Interobserver agreementTimepoint: After 12 months